Artem Elmuratov

Mr. Artem Elmuratov

Genotek Ltd.
+1
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2020 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
Dmitry VerbenkoDmitry Verbenko
Dmitry Verbenko
AKArfenya Karamova
Arfenya Karamova
OAOlga Artamonova
Olga Artamonova
Dmitry DeryabinDmitry Deryabin
Dmitry Deryabin
ARAlexandr Rakitko
Alexandr Rakitko
AKAlexey A. Kubanov
Alexey A. Kubanov
One of the target drugs for plaque psoriasis treatment is apremilast, which is a selective phosphodiesterase 4 (PDE4) inhibitor. In this study, 34 moderate-to-severe and severe plaque psoriasis patients from Russia were treated with apremilast for 26 weeks. This allowed us to observe the effectiveness of splitting patient cohorts based on clinical outcomes, which were assessed using the Psoriasis Area Severity Index (PASI). In total, 14 patients (41%) indicated having an advanced outcome with delta PASI 75 after treatment; 20 patients indicated having moderate or no effects. Genome variability was investigated using the Illumina Infinium Global Screening Array. Genome-wide analysis revealed apremilast therapy clinical outcome associations at three compact genome regions with undefined functions situated on chromosomes 2, 4, and 5, as well as on a single single-nucleotide polymorphism (SNP) on chromosome 23. Pre-selected SNP sets were associated with psoriasis vulgaris analysis, which was used to identify four SNP-associated targeted therapy efficiencies: IL1β (rs1143633), IL4 (IL13) (rs20541), IL23R (rs2201841), and TNFα (rs1800629) genes. Moreover, we showed that the use of the global polygenic risk score allowed for the prediction of onset psoriasis in Russians. Therefore, these results can serve as a starting point for creating a predictive model of apremilast therapy response in the targeted therapy of patients with psoriasis vulgaris.

25 October 2018 in Cells
Verified
Journal Article
Open access
PDF file
MSMariia Shorokhova
Mariia Shorokhova
TGTat'yana M Grinchuk
Tat'yana M Grinchuk
OAOlga V Anatskaya
Olga V Anatskaya
AVAlexander E Vinogradov
Alexander E Vinogradov
LALarisa Alekseenko
Larisa Alekseenko
NNNikolai N. Nikolsky
Nikolai N. Nikolsky
Temperature is an important exogenous factor capable of leading to irreversible processes in the vital activity of cells. However, the long-term effects of heat shock (HS) on mesenchymal stromal cells (MSC) remain unstudied. We investigated the karyotype and DNA repair drivers and pathways in the human endometrium MSC (eMSC) survived progeny at passage 6 after sublethal heat stress (sublethal heat stress survived progeny (SHS-SP)). G-banding revealed an outbreak of random karyotype instability caused by chromosome breakages and aneuploidy. Molecular karyotyping confirmed the random nature of this instability. Transcriptome analysis found homologous recombination (HR) deficiency that most likely originated from the low thermostability of the AT-rich HR driving genes. SHS-SP protection from transformation is provided presumably by low oncogene expression maintained by tight co-regulation between thermosensitive HR drivers BRCA, ATM, ATR, and RAD51 (decreasing expression after SHS), and oncogenes mTOR, MDM2, KRAS, and EGFR. The cancer-related transcriptomic features previously identified in hTERT transformed MSC in culture were not found in SHS-SP, suggesting no traits of malignancy in them. The entrance of SHS-SP into replicative senescence after 25 passages confirms their mortality and absence of transformation features. Overall, our data indicate that SHS may trigger non-tumorigenic karyotypic instability due to HR deficiency and decrease of oncogene expression in progeny of SHS-survived MSC. These data can be helpful for the development of new therapeutic approaches in personalized medicine.

13 June 2023 in European Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
EKElena Kovalenko
Elena Kovalenko
EVEkaterina Vergasova
Ekaterina Vergasova
OSOlesya Shoshina
Olesya Shoshina
IPIaroslav Popov
Iaroslav Popov
AIAnna Ilinskaya
Anna Ilinskaya
ARAlexandr Rakitko
Alexandr Rakitko

10 December 2017 in Stem Cells International
Verified
Journal Article
Open access
PDF file
AVAlexander E Vinogradov
Alexander E Vinogradov
MSM. A. Shilina
M. A. Shilina
OAOlga V Anatskaya
Olga V Anatskaya
LALarisa Alekseenko
Larisa Alekseenko
IFI. I. Fridlyanskaya
I. I. Fridlyanskaya
NNN. N. Nikolsky
N. N. Nikolsky
High temperature is a critical environmental and personal factor. Although heat shock is a well-studied biological phenomenon, hyperthermia response of stem cells is poorly understood. Previously, we demonstrated that sublethal heat shock induced premature senescence in human endometrial mesenchymal stem cells (eMSC). This study aimed to investigate the fate of eMSC-survived sublethal heat shock (SHS) with special emphasis on their genetic stability and possible malignant transformation using methods of classic and molecular karyotyping, next-generation sequencing, and transcriptome functional analysis. G-banding revealed random chromosome breakages and aneuploidy in the SHS-treated eMSC. Molecular karyotyping found no genomic imbalance in these cells. Gene module and protein interaction network analysis of mRNA sequencing data showed that compared to untreated cells, SHS-survived progeny revealed some difference in gene expression. However, no hallmarks of cancer were found. Our data identified downregulation of oncogenic signaling, upregulation of tumor-suppressing and prosenescence signaling, induction of mismatch, and excision DNA repair. The common feature of heated eMSC is the silence of MYC, AKT1/PKB oncogenes, and hTERT telomerase. Overall, our data indicate that despite genetic instability, SHS-survived eMSC do not undergo transformation. After long-term cultivation, these cells like their unheated counterparts enter replicative senescence and die.

Verified
Journal Article
Open access
PDF file
OAOlga V Anatskaya
Olga V Anatskaya
ARAndrei Runov
Andrei Runov
SPSergey V. Ponomartsev
Sergey V. Ponomartsev
VMVonsky S Maxim
Vonsky S Maxim
Artem ElmuratovArtem Elmuratov
Artem Elmuratov
AVAlexander E Vinogradov
Alexander E Vinogradov
Many cardiovascular diseases originate from growth retardation, inflammation, and malnutrition during early postnatal development. The nature of this phenomenon is not completely understood. Here we aimed to verify the hypothesis that systemic inflammation triggered by neonatal lactose intolerance (NLI) may exert long-term pathologic effects on cardiac developmental programs and cardiomyocyte transcriptome regulation. Using the rat model of NLI triggered by lactase overloading with lactose and the methods of cytophotometry, image analysis, and mRNA-seq, we evaluated cardiomyocyte ploidy, signs of DNA damage, and NLI-associated long-term transcriptomic changes of genes and gene modules that differed qualitatively (i.e., were switched on or switched off) in the experiment vs. the control. Our data indicated that NLI triggers the long-term animal growth retardation, cardiomyocyte hyperpolyploidy, and extensive transcriptomic rearrangements. Many of these rearrangements are known as manifestations of heart pathologies, including DNA and telomere instability, inflammation, fibrosis, and reactivation of fetal gene program. Moreover, bioinformatic analysis identified possible causes of these pathologic traits, including the impaired signaling via thyroid hormone, calcium, and glutathione. We also found transcriptomic manifestations of increased cardiomyocyte polyploidy, such as the induction of gene modules related to open chromatin, e.g., “negative regulation of chromosome organization”, “transcription” and “ribosome biogenesis”. These findings suggest that ploidy-related epigenetic alterations acquired in the neonatal period permanently rewire gene regulatory networks and alter cardiomyocyte transcriptome. Here we provided first evidence indicating that NLI can be an important trigger of developmental programming of adult cardiovascular disease. The obtained results can help to develop preventive strategies for reducing the NLI-associated adverse effects of inflammation on the developing cardiovascular system.

14 May 2025 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
MTMichil Trofimov
Michil Trofimov
VKViacheslav Kudriavskii
Viacheslav Kudriavskii
LSLayal Shaheen
Layal Shaheen
EKElena Kovalenko
Elena Kovalenko
KVKate Vergasova
Kate Vergasova
ARAlexandr Rakitko
Alexandr Rakitko